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2Abstract
Toll-like receptor (TLR) family members recognize specific molecular patterns within pathogens.
Signaling through TLRs results in a proximal event that involves direct binding of adaptor proteins to the
receptors. We observed that TIRAP/Mal, an adaptor protein for TLR2 and TLR4, binds protein kinase C
(PKC). TIRAP/Mal GST-fusion protein and a TIRAP/Mal antibody were able to precipitate PKC from rat
peritoneal macrophage and THP1 cell lysates. Truncation mutants of TIRAP/Mal showed that the TIR domain
of TIRAP/Mal is responsible for binding. TLR2- and TLR4-mediated phosphorylation of p38 MAPK, IKK, and
I
B in RAW264.7 cells were abolished by depletion of PKC. These results suggest that PKC binding to
TIRAP/Mal promotes TLR signaling events.
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1. Introduction
The Toll-like receptor (TLR) family plays a central role in regulating innate immunity. TLRs recognize
conserved microbial products such as lipopolysaccharide (LPS), peptidoglycan, flagellin, and unmethylated
CpG motifs in bacterial DNA (Kaisho and Akira, 2001). TLR signaling is initiated from the Toll-interleukin-1
receptor (TIR)-domain, a ~200 amino acid motif found in the cytosolic domain of all TLRs and the IL-1
receptor. Some adaptor molecules also contain TIR domains and bind to the TIR domains of TLR through
stimulation-induced TIR/TIR interactions (Akira, 2003; Yamamoto et al., 2003). The TLR adaptor family has
four known members, MyD88, TIRAP/Mal, TICAM-1/TRIF, and TICAM-2/TRAM. Studies with mice that
lack the individual adaptors have defined a specific role for each one. MyD88 is shared by all TLRs except
TLR3, while TIRAP/Mal only binds to TLR2 and TLR4, TICAM-1 binds exclusively to TLR3 and TLR4, and
TICAM-2 only binds to TLR4 (Yamamoto et al., 2004; Oshiumi et al., 2003a; Oshiumi et al., 2003b). The
diversity of adaptor molecules may partially account for the variety of inflammatory responses to different
ligands.
3MyD88 was the first adaptor protein to be identified, and its signaling pathway is now well characterized
(Akira, 2003). Once MyD88 is recruited to the TLR, it associates with the serine/threonine kinases, IRAK-1
(IL-1R associated kinase-1) and IRAK-4. This association leads to IRAK-1 phosphorylation by IRAK-4 or
other IRAK-1 molecules, a key event that allows IRAK-1 to bind TRAF6. This complex activates TAK-1, a
MAPKKK family member, which activates SAPK/JNK and p38MAPK. TAK1 acts at a divergence point in the
TLR signaling pathway because it can also activate IKK, a protein kinase responsible for I
B degradation and
subsequent NF-
B activation.
The PKC family consists of at least 11 isoforms that are classified into three main subfamilies based on
their homology and cofactor requirements for activation: the conventional PKC, I, II and  subfamily, which
is diacylglycerol (DAG)- and calcium-dependent, the novel PKC, ,  and  subfamily, which is
DAG-dependent and calcium-independent, and the atypical PKC,  and 	 family, which is
phospholipid-dependent. There is growing evidence for a fundamental role of the PKC isoforms, PKC (Platten
et al., 2003),  (Aksoy et al., 2004; Castrillo et al., 2001),  (Chen et al., 1998), 	 (Mamidipudi et al., 2004),
and  (Hu et al., 2002; Monick et al., 2000), in the regulation of LPS-induced events in macrophages and
dendritic cells. However, it is still unknown how PKCs are integrated into the TLR signaling pathway. In this
study, we identified PKC as a signaling molecule that binds to TIRAP/Mal. Functional analysis suggests that
PKC participates in the activation of both NF-
B and MAPK cascades induced by TLR signaling.
2. Materials and Methods
2. 1. Materials
LPS (E. coli, serotype 0111: B4), bovine serum albumin (fatty acid free), GF109203X, staurosporine,
histone III-S, poly I:C, and ATP were purchased from Sigma (St. Louis, MO). Phosphatidylserine and
phosphatidylinositol were bought from Matreya (Pleasant Gap, PA), raytide, a peptide substrate of tyrosine
kinases, was purchased from Oncogene Science (Uniondale, NY), rGM-CSF came from PeproTech EC (London,
UK);, Glutathione-Sepharose CL-4B and pGEX4T2 were bought from Amersham Biosciences (UK), antibodies
raised against PKCs were bought from Transduction Laboratories (Lexington, KY), anti-phospho-p38 MAPK,
4anti-phospho-SAPK/JNK, and anti-phospho-IKK were bought from Cell Signaling (Beverly, MA), and
anti-phospho-I
B came from Santa Cruz (Santa Cruz, CA). Anti-TIRAP/Mal and anti-IRAK polyclonal
antibodies were prepared by immunizing rabbits with full-length rTIRAP/Mal or recombinant C-terminal
IRAK-1 peptide (636-end), respectively. [-32P]ATP was purchased from New England Nuclear, and Phos-tag
(1,3-bis[bis(pyridine-2-ylmethyl)amino] propan-2-olato dizinc(II) complex (Kinoshita et al., 2006) was kindly
donated by Dr. T. Koike (Hiroshima University).
2. 2. Plasmids
Total RNA was extracted from human monocytes that had been cultured for ten days with 10 ng/ml
GM-CSF using an RNeasy Mini Kit (Qiagen) according to the manufacturer’s protocol. Complementary DNA
from TIRAP/Mal, IRAK-1, and MyD88 were amplified by RT-PCR using primers based on the sequences of
the GenBank accession numbers AF406652, L76191 and U70451, respectively. The coding sequences for
TIRAP/Mal and MyD88 were subcloned into pGEX-4T-2 in-frame with the GST coding sequence. TIRAP/Mal
was also cloned into pcDNA3.1 with an N-terminal HA-tag. pcDNA3-FLAG-PKC (GenBank accession
number M18330) was kindly donated by Dr. Yoshitaka Ono (Biomedical Research Center, Kobe). Truncation
mutants of HA-Mal were made by PCR.
2. 3. Cells
HEK293T cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Nissui, Japan)
supplemented with 10% FCS in humidified 5% CO2 at 37°C. A mouse macrophage-like cell line, RAW264.7,
was maintained in RPMI1640 medium fortified with 2.5g/L glucose and 10% FCS in humidified 5% CO2 at
37°C. Peritoneal macrophages were harvested from female Donryu rats. Briefly, animals were injected
intra-peritoneally with 20 ml of a 3% thioglycollate broth. After four days, peritoneal exudate cells were
harvested by washing the peritoneal cavity with ice-cold PBS. The cells were resuspended in RPMI1640
medium supplemented with 10% FCS and seeded at approximately 1.5x10
7
cells/10-cm dish for the pull-down
assay, or 3x10
6
cells/well of a 6-well plate for immunoprecipitation, and incubated in humidified 5% CO2 at
37°C for 1-2 h. Non-adherent cells were removed by washing vigorously with PBS and the attached cells were
5used as macrophages. Macrophages were incubated in humidified 5% CO2 at 37°C in the presence or absence of
LPS.
2. 4. Transfection
293T cells were cultured in 6-well plates prior to the protein-protein interaction assay. The cells were
seeded at 5x10
5
cells/well for 24h before transfection using FuGENE 6 (Roche) according to the manufacturer’s
protocol. After 24 h, cells were lysed for immunoprecipitation. To detect expression of IRAKs and PKCs, 293T
cells were plated at 5x10
5
cells/10-cm dish for 24 h before calcium phosphate transfection. The media was
changed 20-24 h after transfection, and 48 h later the cells were lysed for immunoprecipitation.
2. 5. GST-fusion proteins
BL21 (DE3) cells were transformed with the GST-TIRAP/Mal or GST-MyD88 plasmid, and grown to
mid-log phase. Protein production was induced with 1 mM isopropyl-1-thio--D-galactopyranoside for 4 h at
30°C. The cells were harvested by centrifugation, lysed with lysis buffer (TBS containing 0.5% Triton X-100
and 1 mM PMSF), and sonicated 3x for 30 sec with a needle sonicator at 40-50% power. The clarified
supernatants were incubated with glutathione-Sepharose at 4°C for 60 min. The beads containing the
recombinant proteins were washed six times with lysis buffer.
2. 6. Pull-down with GST-proteins
After removal of cell culture supernatants, the cells were washed once with ice-cold PBS containing 1
mM EDTA, 10 mM NaF and 1 mM Na3VO4, and immediately incubated in 1 ml of lysis buffer (1 mM EDTA,
25 mM Tris-HCl (pH7.4), 100 mM NaCl, 30 mM NaF, 1% Nonidet P-40, 1 mM Na3VO4, 1 mM PMSF, 2 μM
leupeptin, and 20 μM PA-PMSF) for 10 min on ice. The cell lysates were centrifuged at 15,000 rpm for 10 min.
The resultant supernatants were precleared with glutathione-Sepharose at 4°C for 60 min and incubated with the
GST-fusion proteins immobilized on glutathione-Sepharose at 4°C for 120 min. The Sepharose beads with the
fusion proteins were spun briefly in a microfuge and washed four times with ice-cold lysis buffer. For the in
6vitro kinase assay, the beads were further washed with kinase assay buffer (25 mM Tris-HCl, pH7.5, 0.1 mM
EDTA, and 0.1 mg/ml BSA).
2. 7. Immunoprecipitation
Cell lysates were prepared as above, and incubated with the appropriate antiserum for at least 60 min on
ice. A slurry of pre-washed protein A-Sepharose CL-4B (30% slurry, 50 μl) was added to each sample and
incubated on a rotator at 4°C for an additional 2 h. The samples were spun briefly in a microfuge and washed
four times with ice-cold lysis buffer. For the in vitro kinase assay, the beads were further washed with kinase
assay buffer as described above.
2. 8. In vitro kinase assay
The kinase activities of the GST-TIRAP/Mal and GST-MyD88 fusion proteins were determined by
incubating the glutathione-beads with [-32P]ATP and protein substrates. The glutathione-beads were suspended
in 20 μl kinase assay buffer containing the appropriate substrates and protein kinase inhibitors. Unless otherwise
specified, phospholipids were added to the reaction mixture as lipid vehicles made by sonication. The reaction
was initated by adding 10 μl of the reaction mixture fortified with 0.3 mM [-32P]ATP (1 μCi), 5μg histone III-S
and 30 mM MgCl2, continued at 30˚C for 60 min, and terminated by addition of SDS sample buffer. After
separation of the proteins on SDS-PAGE, the gels were stained with coomassie brilliant blue (CBB) and the
protein bands were analyzed with an imaging analyzer to estimate the degree of substrate phosphorylation.
Anti-IRAK and anti-flag-PKC immunoprecipitates were also assessed using the methodology described above.
2. 9. Western blotting
GST-fusion proteins immobilized on glutathione-Sepharose beads, anti-TIRAP/Mal immunoprecipitates,
anti-flag immunoprecipitates of PKC, or total cell lysates were heated at 100˚C for 3 min in 30 μl of the
7sample buffer containing 62.5 mM Tris (pH 6.8), 1% SDS, 10% glycerol, 5% 2-mercaptoethanol, and 0.02%
bromophenol blue. The proteins were separated by SDS-PAGE on a 10% slab gel and transferred
electrophoretically to a polyvinylidene difluoride (PVDF) membrane (Millipore). The membranes were blocked,
incubated with the appropriate antibodies, and visualized by enhanced chemiluminescence.
2. 10. RNA Interference
Two sets of oligonucleotides were cloned into the pH1 vector to express PKC siRNA hairpins
downstream of the human H1 RNA promoter, as described previously (Sasai et al., 2005). The following
sequences were used: 5’-GAACGCTTCAACATCGACA-3 and 5’-GGCCGTGTTATCCAGATTG-3. 293 cells
were transfected with 100 ng of pH1-empty or 50 ng of each pH1-siPKC vector using FuGENE6 Transfection
Reagent. 5-10x10
6
RAW264.7 cells were transfected by electroporation in a 300 L final volume at 250
V/950F (Gene Pulser II, Bio-Rad). 24 h after transfection, puromycin (2 g/mL for 293T cells and 5 g/mL
for RAW264.7 cells) was added to the cells, and incubation was continued for several days. Puromycin-resistant
colonies were replated. To determine the efficiency of gene silencing, total RNA was isolated with RNeasy
(Qiagen, Hilden, Germany) and mRNA was assessed by RT-PCR.
3. Results
3. 1. GST-TIRAP/Mal fusion protein associates with protein kinases
We first determined whether TIRAP/Mal interacts with protein kinases. Recombinant GST-TIRAP/Mal
was incubated with rat peritoneal macrophage lysates. Proteins associating with the fusion protein were
analyzed in the in vitro kinase assay using histone III-S as a substrate. Phosphorylation of histone III-S was
prominent when phospholipids were included in the assay mixture (Fig. 1, upper panel). TIRAP/Mal and histone
III-S levels remained unchanged during the kinase assay (Fig. 1, lower panel), and GST alone was not
associated with protein kinases activity (Fig. 1B). A tyrosine kinase substrate, raytide, was not phosphorylated
by TIRAP/Mal-associated kinase (data not shown). Since PKC family members are phospholipid-dependent, we
8tested the effect of PKC inhibitors on the protein kinase activities. A PKC inhibitor with a broad spectrum,
GF109203X, inhibited histone III-S phosphorylation by TIRAP/Mal-associated kinases, while Gö6976, a
specific inhibitor of conventional PKCs, did not (Fig. 2A, upper panels). MyD88 also associated with some
protein kinases, as shown by histone III-S phosphorylation (Fig. 2B). MyD88-associated activity was
susceptible to both GF109203X and Gö6976 (Fig. 2B, upper panels) indicating that the bound kinases are
different from those associated with TIRAP/Mal. Another PKC inhibitor, staurosporine, strongly inhibited both
MyD88-associated and TIRAP/Mal-associated kinases (data not shown). Since MyD88 is known to bind IRAK
family members, we analyzed these as potential TIRAP/Mal-associated protein kinases. However, GF109203X,
which inhibited protein kinase activity associated with TIRAP/Mal (Fig. 2A, left upper panel), failed to inhibit
kinase activity in lysates from IRAK-1 and IRAK-4 transfected 293T cells (data not shown).
3. 2. Identification of PKC and  as TIRAP/Mal-associated kinases
Whole cell lysates of rat macrophages were western blotted with a series of specific antibodies against the
PKC isoforms. As shown in Fig. 3A, PKC, 	, and  were the dominant PKC subtypes observed by the
employed antibodies, though PKC and  were also observed. The lysates were mixed with GST-TIRAP/Mal
immobilized on glutathione-Sepharose beads, and protein associated with the beads was western blotted with
specific antibodies. PKC and  bound GST-TIRAP/Mal (Fig. 3A), while GST alone did not bind any PKCs
(data not shown). A point mutation of TIRAP/Mal (P125H) known to impair the ability of this adaptor to bind
TLR4 and MyD88 (Horng et al., 2001; Fitzgerald et al., 2001; Xu et al., 2000), did not alter the ability of
TIRAP/Mal to bind PKC and  (Fig. 3A). PKC and  binding to TIRAP/Mal was also observed in the lysates
of monocytic THP-1 cells (data not shown).
To confirm the binding of TIRAP/Mal to PKC, RAW264.7 cells were transfected with shRNA probes
that targeted PKC. The probes prevented PKC expression without affecting expression of a control protein,
p67
phox
(see Fig. 5). Lysates of PKC-depleted cells were incubated with recombinant GST-TIRAP/Mal and
protein associated with this fusion protein was assessed using the in vitro kinase assay. Depletion of PKCȺ
markedly decreased the protein kinase activity associated with GST-TIRAP/Mal (Fig. 1B). As shown in Fig. 3B,
9a polyclonal antibody against TIRAP/Mal was used to analyze its interaction with PKCȺ. This antibody was
incubated with rat peritoneal macrophage lysates, and the immune complex was analyzed using a monoclonal
antibody against PKC. The results confirmed that TIRAP/Mal associates with PKC and showed that this
association is constitutive, remaining unchanged after treatment with LPS. The anti-TIRAP/Mal antibody
precipitated the histone III-S kinase activity from wild type RAW264.7 cell lysates (Fig. 3C), and kinase activity
also remained unchanged by LPS treatment. When a similar experiment was performed using the lysate from
PKC-deficient cells, kinase activity was barely detected in the immune complex (Fig. 3C). As shown in Fig.
3D, RAW264.7 cell lysates were mixed with anti-PKC, and the immune complex was analyzed by Phos-tag, a
probe used to detect phosphorylated proteins (Kinoshita et al., 2006). The proteins in the immune complex of
anti-PKC were separated by SDS-PAGE, transferred to PVDF membrane, and analyzed by Phos-tag.
Interestingly, LPS increased the phosphorylation of several proteins in the immune complex. PKC was
constitutively phosphorylated, however, the level of phosphorylation was unaffected by LPS treatment.
293T cells were then transfected with flag-PKC along with HA-TIRAP/Mal (Fig. 4). The cell lysate was
mixed with an anti-flag antibody, and immune complexes were analyzed using an anti-HA antibody. The results
confirmed that PKC binds to the full length TIRAP/Mal (WT). The TIR domain of TIRAP/Mal (86 to end)
bound flag-PKC, while HA-TIRAP/Mal lacking the TIR domain (TIR) did not complex with flag-PKC.
3. 3. Possible involvement of PKC in LPS-induced activation of MAPKs and IKK
TLR ligation is known to activate MAPKs and IKK. As shown in Fig. 5A, stimulation of RAW264.7 cells
with LPS, a TLR4 ligand, induced the phosphorylation of IKK, p38 MAPK, and I
B. The LPS-induced events
were completely abolished in PKC-deleted cells (Fig. 5A). Similar results were obtained in cells treated with
Malp2, a TLR2/TLR6 ligand (Fig. 5B). These results indicate that PKC plays a critical role in
TIRAP/Mal-dependent signaling pathways. Poly I:C is a TLR3 ligand that binds TICAM-1 but not TIRAP/Mal.
Poly I:C, like LPS and Malp2, induced the phosphorylation of IKK, p38 MAPK, and I
B (Fig. 5C). In
PKC-deficient cells, IKK and I
B phosphorylation were severely impaired but still observable (Fig. 5C).
Interestingly, the phosphorylation of p38 MAPK was not altered by the 60-90 min treatment (Fig. 5C).
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Phosphorylation induced by calyculin A, a pan-inhibitor of Ser/Thr phosphatases, was not affected by
PKC-depletion (Fig. 5D).
4. Discussion
Numerous studies have reported that LPS induces PKC activation (Aksoy et al., 2004; Shinji et al., 1994).
A deficiency in LPS-induced translocation of novel and conventional PKC is observed in macrophages from
C3H/HeJ mice, which harbor a TLR4 point mutation (Shinji et al., 1994). PKC, an atypical PKC subfamily
member, is proposed to function in LPS-induced IRAK activation (Hu et al., 2002), and PKC, a novel PKC, is
indispensable for LPS-induced IL-12 production by dendritic cells (Aksoy et al., 2002). PKC-deficient murine
macrophages display a major defect in their capacity to clear bacterial infection (Castrillo et al., 2001).
It is reported that LPS-induced activation of NF-
B is inhibited by rottlerin (Kontny et al., 2000).
Although rottlerin is often utilized as an inhibitor of PKC, a recent study indicated that the compound do not
inhibit PKC (Davies et al., 2000). We confirmed the inability of rottlerin to inhibit PKC using a recombinant
enzyme (data not shown). Thus, the present study was performed to provide a new line of evidence suggesting
that PKC is involved in TLR signaling. We observed that the adaptor protein, TIRAP/Mal, is associated with
protein kinase activity (Fig. 2) that is unaffected by rottlerin (data not shown). The effects of phospholipid and
pharmacological inhibitors suggested involvement of PKC family members. Immunological analysis indicated
that PKC and , members of the novel PKC subfamily, were associating with TIRAP/Mal (Fig. 3A). Indeed,
truncated mutants of TIRAP/Mal showed that the TIR domain is required for binding to PKC (Fig. 4). PKC,
another novel isoform, is recently shown to be a critical component of the TLR4 signaling pathway (Aksoy et al.,
2002). It appears that some structures that are common in novel PKC family members may associate favorably
with TIRAP/Mal.
Constitutively active PKC, another novel PKC isoform, is a potent activator of NF-
B and AP-1 in
Jurkat T cells (Lin et al., 2000; Baier-Bitterlich et al., 1996). Activation of IKK and NF-
B by TCR signaling
depends on PKC or novel PKCs (Shinohara et al., 2005; Sommer et al., 2005; Krappmann et al., 2001).
Although this finding suggests that novel PKCs are involved in the signaling pathway leading to NF-
B
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activation, it is not clear whether each PKC isozyme has a specialized function. The substrate specificity of PKC
isoforms is redundant, so their physiological roles in certain cell types may depend on their relative abundance,
localization, and cellular environment. In this study, we observed that TLR2- and TLR4-mediated activation of
IKK was completely abolished in PKC-deficient RAW264.7 cells (Fig. 5). Considering that PKC is the most
abundant novel PKC in macrophages, it is not surprising that this subtype plays a dominant role in these cells. In
fact, activation of NF-
B by TLR2, TLR4, TLR3, and TLR9 was also attenuated in PKC-deficient cells (data
not shown). TLR3-mediated responses were attenuated but still observed in these cells, while the TLR2/4
responses were completely abolished (Fig. 5). Therefore, we have to consider two independent roles of PKC in
TLR signaling. One is specific for TLR2/4, and another is common to all TLRs.
TICAM-1/TRIF did not bind to PKC (data not shown). In addition, ligation of TLR3 with polyI:C did
not increase the phosphorylation of PKC-associated proteins (data not shown) where TLR4 ligation
considerably increase the phosphorylation (Fig. 3D). It is very likely that PKC interacts specifically with
TIRAP/Mal. There may be another mechanism by which PKC regulates TLR-mediated signals. We have
recently observed that phosphatidylinositol 3-kinase (PI3K) and Akt activity is greatly increased in the PKC
deficient cells (to be published elsewhere). As reported by numerous studies and also by us, activation of
PI3K/Akt resulted in a suppression of TLR-mediated NF-
B activation. The negative regulation by PI3K of
TLR is commonly observed with all TLR signals (Hazeki et al., 2006). Based on this, the augmentation of
PI3K activity in PKC deficient cells may be responsible for the general impairment of TLR signals.
TIRAP/Mal is only shared by TLR2 and TLR4, while MyD88 is shared by all the TLRs (Yamamoto et al.,
2003). Thus, TIRAP/Mal-binding proteins are good candidates for a signaling molecule that induces specific
responses to TLR2 and TLR4. Although the signaling pathway downstream of MyD88 is well characterized,
little is known about TIRAP/Mal signaling except that it specifically associates with PKR (Horng et al., 2001)
and IRAK-2 (Fitzgerald et al., 2001). This study suggests that PKC also interacts specifically with TIRAP/Mal.
Interactions between TIRAP/Mal and Btk, a Tec family tyrosine kinase, are also reported. TIRAP/Mal is
phosphorylated by Btk and subject to proteosomal degradation, which results in negative feedback termination
of the innate immune response (Mansell et al., 2006). Interestingly, PKC inhibits the function of Tec family
tyrosine kinases (Saharinen et al., 1997). It is intriguing to consider that the inhibition of Btk is one of the
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specialized functions of PKC. Another recent study revealed that TIRAP/Mal associates with TRAF6 (Mansell
et al., 2004), which binds to numerous functional proteins including MyD88 (Kawai et al., 2004), IRAK-1
(Jiang et al., 2002), TRIF (TICAM-1; Sato et al., 2003), TBK-1 (Sato et al., 2003), TAB1/2 (Qian et al., 2001),
TAK-1 (Qian et al., 2001), IRF-7 (Kawai et al., 2004), ECSIT (Kopp et al., 1999), -arrestin (Wang et al., 2006),
Src family tyrosine kinase (Wong et al., 1999), Ras (McDermott and O'Neill, 2002), and aPKC-interacting p62
(Sanz et al., 2000). These proteins are candidates for regulation by PKC, as described below.
We showed that LPS increases the association between phosphorylated proteins and PKC (Fig. 3D).
PKC is activated when tyrosine residues on this protein become phosphorylated (Konishi et al., 2001). Since
ligation of TLR4 increases tyrosine kinase activity in cells (Hazeki et al., 2003), it is possible that
tyrosine-phosphorylated PKC phosphorylates other proteins. We did not observe any effect of LPS on the
tyrosine-phosphorylation of PKC, however (data not shown), and the PKC activity associated with
TIRAP/Mal was also unaffected by LPS (Fig. 3C). Another possibility is that PKC is recruited to the TLR
signaling complex, since PKC translocation is often observed in intact cells. We have observed that the
association between PKC and TIRAP/Mal is not dependent on receptor ligation (Fig. 3B). Thus, LPS-induced
recruitment of TIRAP/Mal to the TLR or TRAF6 may be the event that results in increased phosphorylation of
proteins in the immune complex formed by anti-PKC. LPS induces the association between TIRAP/Mal and
TRAF6, which binds to PKC and its substrates, respectively. Further study is necessary to define the detailed
signaling mechanism.
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FIGURE LEGENDS
Fig. 1. Asociation of protein kinase activity with GST-TIRAP/Mal. (A) GST-TIRAP/Mal immobilized on
glutathione-Sepharose beads were incubated with rat macrophage lysates. The beads were washed four times
and assayed for protein kinase activity using [-32P]ATP and histone III-S as substrates in the presence (+) or
absence (-) of phosphatidylserine and diacylglycerol (PS/DG). The reaction was terminated by the addition of
SDS sample buffer. (B) GST-TIRAP/Mal or control GST immobilized on glutathione-Sepharose were incubated
with lysates from wild type RAW264.7 cells or PKC deficient cells (). Protein kinase activity associated
with the beads was determined in the presence of the phospholipids. (A, B) The phosphorylated proteins were
visualized using an imaging analyzer (Autoradiography). Histone III-S and the fusion proteins were stained with
CBB on the same gels. Positions of molecular mass markers (kDa) are indicated on the left of the panel, while
the positions of the proteins are indicated on the right in (A). The position of the proteins are indicated on the
left of the panel in (B).
Fig. 2. Effects of PKC inhibitors on the protein kinase activity bound to GST-TIRAP/Mal and GST-MyD88.
GST-TIRAP/Mal (A) or GST-MyD88 (B) immobilized on glutathione-Sepharose was incubated with rat
macrophage lysates. The beads were washed and assayed for protein kinase activity using [-32P]ATP and
histone III-S. Increasing concentrations of GF109203X or Gö6976 were added to the assay mixture. Protein
phosphorylation was visualized with an imaging analyzer (upper panels). The amounts of histone III-S and
fusion proteins on the same gels were detected by CBB staining (lower panels). Positions of the molecular mass
markers (kDa) are indicated on the left of the panels, while the positions of the proteins are indicated on the
right.
Fig. 3. PKC binds GST-TIRAP/Mal. (A) GST-TIRAP/Mal or its mutant (P125H) immobilized on
glutathione-Sepharose were incubated with rat macrophage lysates. The bound proteins were analyzed by
immunoblotting with a series of anti-PKC antibodies as indicated at the top of the panel. Total macrophage
lysate was also immunoblotted (top panel). (B) Rat macrophages were stimulated with 100 ng/ml LPS for the
17
times indicated at the top of the panel. The cell lysates were immunoprecipitated with anti-TIRAP/Mal antibody
or control IgG and the proteins in the immune complex were analyzed by immunoblotting with anti-PKC.
Total cell lysates were also analyzed as a positive control. The positions of PKC and TIRAP/Mal are indicated
on the left of the panel. (C) Wild type RAW264.7 cells or PKC-dedficient cells () were stimulated with LPS.
The lysates were immunoprecipitated with anti-Mal antibody and the immunoprecipitates were analyzed by in
vitro kinase assay. (D) Wild type RAW264.7 cells were stimulated with 100 ng/ml LPS. The cell lysates were
immunoprecipitated with anti-PKC antiboody and phosphorylated proteins were detected using Phos-tag.
Fig. 4. The TIR domain of TIRAP/Mal associates with PKC. 293T cells were transfected with 0.5 μg of
flag-PKC with HA-TIRAP/Mal (WT), HA- TIRAP/Mal-TIR (TIR, 86-end), or HA-TIRAP/Mal-ȢTIR (ȢTIR,
1-85) as indicated. PKC was immunoprecipitated from the cell lysates with an anti-flag antibody. The proteins
in the immune complex were separated by SDS-PAGE and blotted with an anti-HA antibody (top panel) or
anti-flag antibody (middle panel). The amount of HA-TIRAP/Mal in the total cell lysate was determined by
blotting with an anti-HA antibody (lower panel). The positions of the proteins are indicated on the left of the
panel.
Fig. 5. Possible involvement of PKC in TLR-mediated activation of p38MAPK and NF-
B. RAW264.7 cells
were transfected with two PKC-shRNAs (10 g each) or empty vector (20 g) by electropotation. After 24 h, 7
g/mL of puromycin was added and the cells were cultured for four weeks, changing the medium every five
days. The resistant colonies were plated in fresh medium without puromycin and cultured for an additional 24 h.
The cells were stimulated with 10 ng/ml of LPS (A), 0.1 M of Malp2 (B), or 25 g/mL of Poly I:C (C) for the
times indicated at the top of the panels. In (D), the cells were treated with 0.1 M calyculin A for 15 min. The
cell lysates were western blotted with the antibodies indicated at the left of the panels.
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